Weekly AI Compliance News & updates

Editorial Update: Moving to a Monthly Schedule   To ensure we provide the most robust and actionable compliance intelligence for the healthcare AI sector, we are transitioning from weekly to monthly updates. This allows us to focus on high-impact regulatory...

This week (January 12–16, 2026) marked a pivotal shift in AI healthcare regulation globally, characterized by the formalization of oversight and international harmonization. Key highlights include the joint FDA-EMA guiding principles for AI in drug development,...

Between 1st and 9th January 2026, the first full week of the year marks a significant shift from theoretical frameworks to operational infrastructure in AI healthcare governance. Key developments include the UK’s closing of its “AI Growth Lab” consultation, the FDA’s...

Between 12–19 December 2025, the regulatory landscape for AI in healthcare shifted decisively toward national-level consolidation and operational security: the U.S. White House issued a landmark Executive Order to centralize AI policy and preempt state-level...

Between 29 November and 12 December 2025, three major jurisdictions released concrete, actionable regulatory documents demonstrating a rapid shift from high-level principles to mandatory operational controls. The U.S. Department of Health and Human Services (HHS)...

Between 22–28 November 2025, global regulators accelerated the shift from high-level principles to mandatory operational controls, particularly in Canada, which launched its first public AI Register detailing hundreds of government AI systems. The EU continued...

Between 8-21 November 2025 regulators and international bodies emphasised moving from principles to practice: the EU launched COMPASS-AI to operationalise safe clinical AI; the UK (MHRA) published AI Airlock pilot outputs and announced AI drug-safety projects; the FDA...

Between 25 October - 7 November 2025 the international AI-in-healthcare policy landscape shifted from high-level strategy to operational, regulator-facing activity and near-term funding/engagement steps. Notable items in this window include: a WHO call for...

Between 14–24 October 2025 regulators and international bodies emphasised moving from principles to practice: the EU launched COMPASS-AI to operationalise safe clinical AI; the UK (MHRA) published AI Airlock pilot outputs and announced new AI drug-safety projects; the...

Between October 4 and October 13, 2025, Canadian regulatory developments specifically targeting AI in healthcare were modest but significant in signaling direction: the Office of the Privacy Commissioner reaffirmed its AI & privacy priorities, and the FPT...